With this tool, we can study the role of TrkB signalling in different neural subtypes in the short and long term, which will help with developing more effective treatments for neuropsychiatric disorders, such as depression, post-traumatic stress disorder, and drug addiction. This evidence concerns the gene NTRK2 and depressive symptom measurement.